EVP Kathryn E Wengel sold 10,000 JNJ shares at $241.15 for $2,411,500 on 2026-06-11, retaining 114,287 non-derivative shares.
Kathryn E Wengel, EVP and Chief TO and Risk Officer, executed a sale of 10,000 shares at $241.15 on 2026-06-11, reducing her non-derivative holdings from 124,287 to 114,287 shares, a -8.0% reduction of her pre-transaction position. The sale occurred at a price within the 52-week range of $149.04–$251.71, approximately 4.3% below the 52-week high. She retains 32,965 shares through employee stock options (derivative holdings), representing her ongoing equity participation. The transaction is a discrete sale of a specific batch rather than a broader portfolio action, occurring in a company with $24.1B quarterly revenue, $5.2B net income, and a P/E of 27.56.